期刊文献+

国产安非他酮与帕罗西汀治疗老年抑郁症对照研究

A control study of domestic bupropion versus paroxetine in the treatment of senile depession
下载PDF
导出
摘要 目的探讨国产安非他酮与帕罗西汀治疗老年抑郁症的临床疗效及安全性。方法将80例老年抑郁症患者随机分为两组各40例,研究组口服安非他酮治疗,对照组日服帕罗西汀治疗,观察6w。于治疗前及治疗1w、2w、4w、6w末采用汉密顿抑郁量表、汉密顿焦虑量表评定临床疗效,副反应量表评定不良反应。结果治疗6w末,研究组显效率为80.0%,对照组为75.0%,两组无显著性差异(χ^2=0.287,P〉0.05)。汉密顿抑郁量表评分,研究组治疗1w末起,对照组治疗2w末起较治疗前有显著下降(P〈0.01),研究组治疗1w末较对照组下降显著(P〈0.05)。汉密顿焦虑量表评分,研究组治疗2w末起,对照组治疗1w末起较治疗前有显著下降(P〈0.05或0.01);对照组治疗后各时点均较研究组下降显著(P〈0.05)。两组总体不良反应发生率无显著性差异(P〉0.05),但研究组头痛、嗜睡、体重增加发生率显著低于对照组(P〈0.05)。结论国产安非他酮与帕罗西汀治疗老年抑郁症疗效均显著,但安非他酮抗抑郁起效更快,不良反应较轻,而抗焦虑作用不如帕罗西汀。 Objective To compare efficacy and safety between domestic bupropion and paroxetine in the treatment of senile depression. Methods 80 senile depression patients were randomly assigned to two groups of 40 ones each,research group took orally bupropion and control group did paroxetine for 6 weeks. Before treatment and at the end of the the 1st, 2nd, 4th and 6th week, clinical efficacies were assessed with the Hanmilton Depression Scale(HAMD) and the Hanmilton Anxiety Scale(HAMA) and adverse reactions with the Treatment Emergent Symptom Scale(TESS) . Results At the end of the 6th week, obvious effective rates were respectively 80.0% in the research and 75.0% in the control group, which showed no significant difference(P〉0.05). The HAMD scores lowered more significantly singce the end of the 1st week in the research and the 2nd in the control group compared with pretreatment(P〈0.01) ; at the end of the 1st week, those did more significantly in the research than in the control group(P〈0.05). The HAMA scores lowered more significantly singce the end of the 2nd week in the research and the 1st in the control group compared with pretreatment(P〈0.05 or 0.01) ; after treatment, each timepoint score lowered more significantly in the control than in the research group(P〈0.05). There were no significant differences of adverse reactions between the 2 groups(P〉0.05) ,but the incidence of headache, drowsiness and weight gain was significantly lower in the research than in the control group(P〈0.05). ConcLusion Both domestic bupropion and paroxetine are effective on senile depression;but the former takes effect faster,has mild adverse reactions,its antianxiety effect is inferior to the latter.
作者 周为 何庆华
出处 《临床心身疾病杂志》 CAS 2009年第6期494-496,共3页 Journal of Clinical Psychosomatic Diseases
关键词 老年抑郁症 安非他酮 帕罗西汀 汉密顿抑郁量表 汉密顿焦虑量表 副反应量表 Senile depression bupropion paroxetine HAMD HAMA TESS
  • 相关文献

参考文献8

  • 1Goldberg RJ. Antidepressant use in the elderly. Current status of nefazodone , venlafaxine and moclobemide [J]. Drugs Aging,1997,11(2) :119.
  • 2Settle EC, Stahl SM, Batey SR, et al. Safety profile of sustained release bupropion in depression : results of three clinical trials[J]. Clin Ther, 1999,21 (3) :454.
  • 3中华医学会精神科分会.中国精神障碍分类与诊断标准[M]:第3版.济南:山东科技出版社,2001.75-78.
  • 4刘文庭,杨长虹,郭华,尤海峰.万拉法新与氟西汀治疗抑郁症对照研究[J].临床心身疾病杂志,2004,10(1):11-12. 被引量:23
  • 5王国府.盐酸安非他酮缓释片治疗老年性抑郁症对照研究[J].临床心身疾病杂志,2009,15(1):59-60. 被引量:3
  • 6王传跃,翟屹民,翁永振,张鸿雁,高成阁,翁正,张秀平,曹毅.安非他酮与阿米替林治疗抑郁障碍的双盲对照研究[J].中华精神科杂志,2006,39(3):169-173. 被引量:23
  • 7Dunner DL, Zisook S, Billow AA, et al. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression[J]. J Clin Psychiatry, 1998,59 (7) :366.
  • 8Kennedy SH, Fulton KA, Bagby RM, et al. Sexual function during bupropion or paroxetine treatment of major depressive disorder[J]. Can J Psychiatry, 2006,51(4) : 234.

二级参考文献14

  • 1李华芳,赵靖平,况伟宏,姚培芬,陈晋东,孙学礼,顾牛范.安非他酮缓释片治疗抑郁症72例的随机双盲双模拟多中心临床研究[J].中国新药与临床杂志,2005,24(8):614-618. 被引量:14
  • 2NeLson JC Mazure CM. Bowers MB JR and Jatlowpi(1991) A Dreliminary, open study of the combination of flouoxetine and desiperamine, for rapid treatment of major depression[J]. Archives of General Psychiatry, 48:303.
  • 3刘春蕊.万拉法新与帕罗西酊治疗老年抑郁症的对照研究[J].中华实用医学杂志,2002,14(2):127-127.
  • 4Nieuwstraten CE, Dolovich LR. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Ann Pharmacother, 2001, 35 : 1608-1613.
  • 5Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry, 1999,60 : 326-335.
  • 6Zung WW. Review of placebo-controlled trials with bupropion. J Clin Psychiatry, 1983, 44(5 Pt 2) :104-114.
  • 7Goodnick PJ, Dominguez RA, DeVane CL, et al. Bupropion slow-release response in depression: diagnosis and biochemistry. Biol Psychiatry., 1998, 44:629-632.
  • 8DeBattista C, Solvason HB, Poirier J, et al. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants. J Clin Psychopharmacol, 2003, 23:27-30.
  • 9Dunner DL, Zisook S, Billow AA, et al. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry, 1998, 59:366-373.
  • 10Croft H, Houser TL, Jamerson BD, et al. Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks. Clin Ther, 2002, 24: 662-672.

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部